Febrile neutropenia due to H1N1 infection: Rare entity
Journal of Oncological Science · 2016
DOI: 10.1016/j.jons.2015.11.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oncological Science, 2016. Verfasst von Ayberk A. Besen und 4 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Febrile neutropenia is one of the most feared complications in actively treated patients in oncology clinics. The impact of H1N1 infection on the management of the febrile neutropenia in endemic areas, especially if the patient is presented with pulmonary symptoms, is not clear. Case report A Forty seven year old male patient diagnosed with mantle cell lymphoma, admitted to our center with neutropenic fever 8 days after chemotherapy. The patient revealed classical symptoms of influenza like headache and myalgia and also had rhonchus and cough supporting lower respiratory tract infection. He was finally diagnosed as influenza A (H1N1) infection.
Conclusion
Influenza infection is an important etiological agent in immunocompromised hosts, namely neutropenic patients, which cause significant morbidity and mortality. Viral etiology and antiviral treatment should also be considered in suspected patients especially during epidemics and pandemics.
Zitieren
APA
Besen, A. A., Kose, F., Mertsoylu, H., Disel, U., & Ozyılkan, O. (2016). Febrile neutropenia due to H1N1 infection: Rare entity. Journal of Oncological Science. https://doi.org/10.1016/j.jons.2015.11.001
Vancouver
Besen AA, Kose F, Mertsoylu H, Disel U, Ozyılkan O. Febrile neutropenia due to H1N1 infection: Rare entity. Journal of Oncological Science. 2016. doi:10.1016/j.jons.2015.11.001
BibTeX
@article{Besen2016,
author = {Besen, Ayberk A. and Kose, Fatih and Mertsoylu, Huseyin and Disel, Umut and Ozyılkan, Ozgur},
title = {Febrile neutropenia due to H1N1 infection: Rare entity},
journal = {Journal of Oncological Science},
year = {2016},
doi = {10.1016/j.jons.2015.11.001}
}
EUVIMED